retatrutide diabetes type 1 How Does Work? Doctor Explains Why It's So Effective Taking Reta with type 1

If you experience unexpected side effects or issues with your GLP-1 medication or delivery device, report these through the MHRA Yellow Card scheme

Total pill revenues are predicted to account for 20% of total GLP-1 drug sales by 2031, and US consumers are expected to represent 60% of the global pill market during that time.

While single-target drugs have reached the market faster in China due to earlier research, multi-target drugs are expected to have stronger long-term effects and greater market acceptance

10.1126/science.1073308 Science 40 WHO | Raised fasting blood glucose (2020)

N Engl J Med (2022) 387:20516

The addition of GIP receptor activation was elegant in its simplicity and delivered tangible results